-
Tytuł:
-
Cardiac scintigraphy with Tc-diphosphonates in cardiac amyloidosis.
-
Autorzy:
-
de Haro-Del Moral FJ; Servicio de Medicina Nuclear, Hospital Universitario Puerta de Hierro, Majadahonda, Madrid, España; Grupo de Trabajo de Cardiología Nuclear de la Sociedad Española de Medicina Nuclear e Imagen Molecular (SEMNIM). Electronic address: .
Pubul-Núñez V; Servicio de Medicina Nuclear, Hospital Clínico Universitario de Santiago de Compostela, Santiago de Compostela, La Coruña, España; Grupo de Trabajo de Cardiología Nuclear de la Sociedad Española de Medicina Nuclear e Imagen Molecular (SEMNIM).
Casáns-Tormo I; Servicio de Medicina Nuclear, Hospital Clínico Universitario de Valencia, Valencia, España; Grupo de Trabajo de Cardiología Nuclear de la Sociedad Española de Medicina Nuclear e Imagen Molecular (SEMNIM).
Jiménez-Heffernan A; Servicio de Medicina Nuclear, Hospital Universitario Juan Ramón Jiménez, Huelva, España; Grupo de Trabajo de Cardiología Nuclear de la Sociedad Española de Medicina Nuclear e Imagen Molecular (SEMNIM).
Ruano-Pérez R; Servicio de Medicina Nuclear, Hospital Clínico Universitario de Valladolid, Valladolid, España; Grupo de Trabajo de Cardiología Nuclear de la Sociedad Española de Medicina Nuclear e Imagen Molecular (SEMNIM).
-
Transliterated Title:
-
Gammagrafía cardíaca con Tc-difosfonatos en la amiloidosis cardíaca.
-
Źródło:
-
Revista espanola de medicina nuclear e imagen molecular [Rev Esp Med Nucl Imagen Mol (Engl Ed)] 2020 Jul - Aug; Vol. 39 (4), pp. 254-266. Date of Electronic Publication: 2020 Jun 06.
-
Typ publikacji:
-
Journal Article; Review
-
Język:
-
English; Spanish; Castilian
-
Imprint Name(s):
-
Original Publication: [Barcelona] : Elsevier España, ©2012-
-
MeSH Terms:
-
Diphosphonates*/administration & dosage
Diphosphonates*/pharmacokinetics
Organotechnetium Compounds*/administration & dosage
Organotechnetium Compounds*/pharmacokinetics
Radiopharmaceuticals*/administration & dosage
Radiopharmaceuticals*/pharmacokinetics
Technetium Tc 99m Pyrophosphate*/administration & dosage
Technetium Tc 99m Pyrophosphate*/pharmacokinetics
Amyloid Neuropathies, Familial/*diagnostic imaging
Cardiomyopathies/*diagnostic imaging
Radionuclide Imaging/*methods
Technetium Tc 99m Medronate/*analogs & derivatives
Algorithms ; Amyloid/chemistry ; Amyloid Neuropathies, Familial/complications ; Bone and Bones/diagnostic imaging ; Calcinosis/diagnostic imaging ; Calcinosis/etiology ; Cardiomyopathies/complications ; Clinical Protocols ; Forms and Records Control ; Heart/diagnostic imaging ; Heart Failure/etiology ; Humans ; Mass Screening ; Myocardium/metabolism ; Myocardium/pathology ; Organ Specificity ; Prealbumin/genetics ; Prognosis ; Technetium Tc 99m Medronate/administration & dosage ; Technetium Tc 99m Medronate/pharmacokinetics ; Whole Body Imaging/methods
-
Contributed Indexing:
-
Keywords: (99m)Tc-difosfonatos; (99m)Tc-diphosphonates; ATTR; Amiloidosis cardíaca; Cardiac amyloidosis; Gammagrafía; Scintigraphy
-
Substance Nomenclature:
-
0 (Amyloid)
0 (Diphosphonates)
0 (Organotechnetium Compounds)
0 (Prealbumin)
0 (Radiopharmaceuticals)
0 (TTR protein, human)
0 (technetium Tc 99m 1,1-diphosphonopropane-2,3-dicarboxylic acid)
5L76I61H2B (Technetium Tc 99m Pyrophosphate)
72945-61-0 (technetium Tc 99m hydroxymethylene diphosphonate)
X89XV46R07 (Technetium Tc 99m Medronate)
-
SCR Disease Name:
-
Amyloidosis, Hereditary, Transthyretin-Related
-
Entry Date(s):
-
Date Created: 20200610 Date Completed: 20210610 Latest Revision: 20210610
-
Update Code:
-
20240104
-
DOI:
-
10.1016/j.remn.2020.03.007
-
PMID:
-
32513587
-
Transthyretin cardiac amyloidosis (ATTR) has traditionally been considered a rare, difficult-to-diagnose and untreatable disease. However, its prevalence is known to be greater than what was previously thought, non-invasive diagnostic methods are available, and that effective treatments are emerging. In this context, cardiac scintigraphy (CS) with 99m Tc-labelled diphosphonates has aroused a noticeable surge in interest by demonstrating high sensitivity and specificity for the reliable, non-invasive diagnosis of ATTR. By way of a guide, this article aims to identify the critical components in the performance of CS that are useful in everyday clinical practice and, thus, help specialists use optimal radiopharmaceuticals, obtain the most appropriate images, interpret the results thereof, and acquaint themselves with those clinical scenarios in which it is convenient to perform CS.
(Copyright © 2020 Sociedad Española de Medicina Nuclear e Imagen Molecular. All rights reserved.)